Market Overview:
The global Durezol market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of eye diseases, increasing awareness about eye care, and growing demand for ophthalmic drugs. By type, the 5ml segment is expected to account for a larger share of the global Durezol market in 2018. By application, the hospital segment is expected to account for a larger share of the global Durezol market in 2018. Geographically, North America is estimated to dominate the global Durezol market in 2018.
Product Definition:
Durezol is a prescription eye drop used to treat inflammation and pain following surgery on the eye. It is a corticosteroid that works by reducing the swelling and inflammation in the eye. Durezol may be used to relieve pain after other types of surgery as well.
5ml:
5ml is a standard dosage for oral solids and liquids. It is also used as an internal dose in injections. The size of the dose depends on the weight and type of drug, but it should be based on scientific principles with a therapeutic index that makes sense to both patient and physician.
The 5ml dosage has been around for quite some time now; however, its usage has always been limited to pharmaceuticals or medical industries due to its huge growth factor (GI tolerance).
10ml:
Durezol is a colorless and highly viscous liquid, which is used as an intermediate in the production of plasticizers, adhesives & sealants, paints & coatings. Durezol has high demand from various end-use industries such as automotive and construction owing to its excellent plasticizing properties. It also acts as a solvent for manufacturing printing inks and rubber chemicals. The product finds application in pharmaceuticals industry for producing tablets with low viscosity content.
Application Insights:
The global demand for durezol has witnessed a paradigm shift owing to the development of injectable products. The injectable segment dominated the overall market in terms of revenue share and is expected to continue its dominance over the forecast period. This can be attributed to factors such as increasing geriatric population, which are more susceptible to infections and requiring long-term medication, growing awareness regarding diseases and rising healthcare costs., etc.to develop new drugs with better quality standards that can withstand physiological conditions in humans thus leading towards an increase in product demand globally.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position through the forecast period owing to high product demand from various end-use industries, such as pharmaceuticals and hospitals. In addition, increasing prevalence of chronic diseases in this region is anticipated to boost product penetration. For instance, according to CDC’s National Center for Health Statistics (NCHS), in 2016 about 11% of adults suffered from arthritis or other joint problems and 6% experienced pain severe enough to require medical attention each month.
Asia Pacific is expected witness lucrative growth over the forecast period owing rising healthcare expenditure coupled with improving infrastructure facilities across emerging economies such as India and China. Moreover, growing target population base along with a large geriatric population base are also contributing toward regional growth rate estimates during the same period; thus making it one of the fastest-growing regions globally by 2030 (USD);).
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The increasing prevalence of various eye diseases and disorders is one of the key growth drivers for the Durezol market. According to a study by The National Eye Institute, around 2 million Americans are affected by glaucoma, while cataracts affect more than 22 million people in the U.S. Furthermore, diabetic retinopathy is also becoming increasingly common, with nearly 7 million Americans suffering from it. This growing incidence of various eye conditions is expected to drive demand for Durezol and other ophthalmic drugs in the coming years.
- Rising awareness about ophthalmic drugs: Ophthalmic drugs such as Durezol are often not well known among patients and healthcare professionals alike. However, there is a growing awareness about these drugs in recent years due to initiatives taken by various drug manufacturers as well as regulatory agencies such as FDA (U .S.). This rising awareness is likely to boost demand for Durezol and other ophthalmic medications in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Durezol Market Research Report
By Type
5ml, 10ml
By Application
Hospital, Drugs Store, Other
By Companies
Novartis, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Durezol Market Report Segments:
The global Durezol market is segmented on the basis of:
Types
5ml, 10ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Store, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Novartis
Highlights of The Durezol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5ml
- 10ml
- By Application:
- Hospital
- Drugs Store
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Durezol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Durezol is a medication used to treat fungal infections. It works by killing the fungus.
Some of the key players operating in the durezol market are Novartis, Novartis.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Durezol Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Durezol Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Durezol Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Durezol Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Durezol Market Size & Forecast, 2018-2028
4.5.1 Durezol Market Size and Y-o-Y Growth
4.5.2 Durezol Market Absolute $ Opportunity
Chapter 5 Global Durezol Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Durezol Market Size Forecast by Type
5.2.1 5ml
5.2.2 10ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Durezol Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Durezol Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Store
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Durezol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Durezol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Durezol Analysis and Forecast
9.1 Introduction
9.2 North America Durezol Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Durezol Market Size Forecast by Type
9.6.1 5ml
9.6.2 10ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Durezol Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Store
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Durezol Analysis and Forecast
10.1 Introduction
10.2 Europe Durezol Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Durezol Market Size Forecast by Type
10.6.1 5ml
10.6.2 10ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Durezol Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Store
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Durezol Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Durezol Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Durezol Market Size Forecast by Type
11.6.1 5ml
11.6.2 10ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Durezol Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Store
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Durezol Analysis and Forecast
12.1 Introduction
12.2 Latin America Durezol Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Durezol Market Size Forecast by Type
12.6.1 5ml
12.6.2 10ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Durezol Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Store
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Durezol Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Durezol Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Durezol Market Size Forecast by Type
13.6.1 5ml
13.6.2 10ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Durezol Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Store
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Durezol Market: Competitive Dashboard
14.2 Global Durezol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Novartis
